Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.


It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.


Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.


*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease
*Describes emerging technologies and therapies, particularly those that overcome drug resistance
*Emphasises common themes in microbial and cancer research

Editor-in-Chief
Y G Assaraf
Technion - Israel Institute of Technology, Haifa, Israel
Associate Editor
K. Martinus Pos
Goethe University, Frankfurt am Main, Germany
Editorial Board
G L Archer
Richmond, Virginia, USA
M C Arendrup
Copenhagen, Denmark
F Baquero, MD
Madrid, Spain
W T Beck PhD
Chicago, Illinois, USA
P. Borst
Amsterdam, Netherlands
C Brancolini
Udine, Italy
H Broxterman
Amsterdam, Netherlands
R. Canton
Madrid, Spain
M Castanheira
North Liberty, Iowa, USA
D. Coen
Boston, Massachusetts, USA
P Courvalin
Paris, France
A.F. Cowman
Parkville, Victoria, Australia
E Cundliffe
Leicester, UK
E. De Clercq
Leuven, Belgium
E.G. de Vries
Groningen, Netherlands
P Dennis
Bethesda, Maryland, USA
S Desai
Rockville, Maryland, USA
M Edelstein
Smolensk, Russian Federation
M. Falagas
Athens, Greece
S Fulda
Ulm, Germany
A Hakanen
Turku, Finland
R E W Hancock
Vancouver, British Columbia, Canada
S Harbarth
Geneva, Switzerland
K.A. Hiramatsu
Tokyo, Japan
S Hoffner
Solna, Sweden
P.J. Houghton
Memphis, USA
R Howe
Cardiff, Wales, UK
P.J. Johnson
Los Angeles, USA
G. Kahlmeter
Växjö, Sweden
M B Kastan MD PhD
Memphis, Tennessee, USA
S B Kaye
London, UK
S L Kelly
Aberystwyth, Wales, UK
B.N. Kreiswirth
Newark, New Jersey, USA
S A Lerner
Detroit, Michigan, USA
S.B. Levy
Boston, Massachusetts, USA
P.J. Morin
New Brunswick, New Jersey, USA
B E Murray MD
Houston, Texas, USA
H. Nikaido
Berkeley, California, USA
C.E. Nord
Stockholm, Sweden
B H Normark
Stockholm, Sweden
M. Ouellette
Quebec City, Quebec, Canada
D. Paterson
Herston, Queensland, Australia
D Perlin
Newark, New Jersey, USA
L Peterson
Cleveland, Ohio, USA
Y.G. Pommier
Bethesda, Maryland, USA
L Pusztai
Houston, Texas, USA
J Rex, MD, FACP
Macclesfield, UK
I Roninson
Albany, New York, USA
B P Rosen PhD
Miami, Florida, USA
M Sällberg
Stockholm, Sweden
O. Samuelsen
Tromso, Norway
D Sanglard
Lausanne, Switzerland
R. Skov
København S, Denmark
A Sparreboom
Bethesda, Maryland, USA
B Stordal
Dublin, Ireland
M. Wainberg
Montreal, Quebec, Canada
T.R. Walsh
Cardiff, Wales, UK
B Wiedemann
Frankfurt am Main, Germany
C R Wolf
Dundee, UK